药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Hexachlorophene
Oxolinic acid
The risk or severity of QTc prolongation can be increased when Oxolinic acid is combined with Chlorpheniramine.
Hexachlorophene
Prajmaline
The risk or severity of QTc prolongation can be increased when Prajmaline is combined with Chlorpheniramine.
Hexachlorophene
Bencyclane
The risk or severity of QTc prolongation can be increased when Bencyclane is combined with Chlorpheniramine.
Hexachlorophene
Cibenzoline
The risk or severity of QTc prolongation can be increased when Cibenzoline is combined with Chlorpheniramine.
Hexachlorophene
Gallopamil
The risk or severity of QTc prolongation can be increased when Gallopamil is combined with Chlorpheniramine.
Hexachlorophene
Cicletanine
The risk or severity of QTc prolongation can be increased when Cicletanine is combined with Chlorpheniramine.
Hexachlorophene
Pilsicainide
The risk or severity of QTc prolongation can be increased when Pilsicainide is combined with Chlorpheniramine.
Hexachlorophene
Givinostat
The risk or severity of QTc prolongation can be increased when Givinostat is combined with Chlorpheniramine.
Hexachlorophene
Triclabendazole
The risk or severity of QTc prolongation can be increased when Triclabendazole is combined with Chlorpheniramine.
Hexachlorophene
Temefos
The risk or severity of QTc prolongation can be increased when Temefos is combined with Chlorpheniramine.
Hexachlorophene
Tetrahydropalmatine
The risk or severity of QTc prolongation can be increased when Tetrahydropalmatine is combined with Chlorpheniramine.
Hexachlorophene
Delafloxacin
The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Chlorpheniramine.
Hexachlorophene
Prulifloxacin
The risk or severity of QTc prolongation can be increased when Prulifloxacin is combined with Chlorpheniramine.
Hexachlorophene
CUDC-907
The risk or severity of QTc prolongation can be increased when CUDC-907 is combined with Chlorpheniramine.
Hexachlorophene
Anisodamine
The risk or severity of QTc prolongation can be increased when Anisodamine is combined with Chlorpheniramine.
Hexachlorophene
Pazufloxacin
The risk or severity of QTc prolongation can be increased when Pazufloxacin is combined with Chlorpheniramine.
Hexachlorophene
Talinolol
The risk or severity of QTc prolongation can be increased when Talinolol is combined with Chlorpheniramine.
Hexachlorophene
Rupatadine
The risk or severity of QTc prolongation can be increased when Rupatadine is combined with Chlorpheniramine.
Hexachlorophene
Bilastine
The risk or severity of QTc prolongation can be increased when Bilastine is combined with Chlorpheniramine.
Hexachlorophene
Difloxacin
The risk or severity of QTc prolongation can be increased when Difloxacin is combined with Chlorpheniramine.